Safety, Tolerability and Preliminary Efficacy of JK1201I in Patients With Small Cell Lung Cancer
Latest Information Update: 06 Dec 2023
At a glance
- Drugs Etirinotecan pegol (Primary)
- Indications Small cell lung cancer
- Focus Adverse reactions
- 20 Dec 2021 New trial record